These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 21204725

  • 1. c-FMS inhibitors: a patent review.
    Burns CJ, Wilks AF.
    Expert Opin Ther Pat; 2011 Feb; 21(2):147-65. PubMed ID: 21204725
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
    Paniagua RT, Chang A, Mariano MM, Stein EA, Wang Q, Lindstrom TM, Sharpe O, Roscow C, Ho PP, Lee DM, Robinson WH.
    Arthritis Res Ther; 2010 Feb; 12(1):R32. PubMed ID: 20181277
    [Abstract] [Full Text] [Related]

  • 4. Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease.
    Patel S, Player MR.
    Curr Top Med Chem; 2009 Feb; 9(7):599-610. PubMed ID: 19689368
    [Abstract] [Full Text] [Related]

  • 5. Small-molecule CSF1R kinase inhibitors; review of patents 2015-present.
    Denny WA, Flanagan JU.
    Expert Opin Ther Pat; 2021 Feb; 31(2):107-117. PubMed ID: 33108917
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications.
    Kumari A, Silakari O, Singh RK.
    Biomed Pharmacother; 2018 Jul; 103():662-679. PubMed ID: 29679908
    [Abstract] [Full Text] [Related]

  • 8. Human monocyte-derived dendritic cells produce macrophage colony-stimulating factor: enhancement of c-fms expression by interleukin-10.
    Rieser C, Ramoner R, Böck G, Deo YM, Höltl L, Bartsch G, Thurnher M.
    Eur J Immunol; 1998 Aug; 28(8):2283-8. PubMed ID: 9710206
    [Abstract] [Full Text] [Related]

  • 9. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
    Ohno H, Kubo K, Murooka H, Kobayashi Y, Nishitoba T, Shibuya M, Yoneda T, Isoe T.
    Mol Cancer Ther; 2006 Nov; 5(11):2634-43. PubMed ID: 17121910
    [Abstract] [Full Text] [Related]

  • 10. M-CSF, c-Fms, and signaling in osteoclasts and their precursors.
    Ross FP.
    Ann N Y Acad Sci; 2006 Apr; 1068():110-6. PubMed ID: 16831911
    [Abstract] [Full Text] [Related]

  • 11. CSF-1 signal transduction.
    Hamilton JA.
    J Leukoc Biol; 1997 Aug; 62(2):145-55. PubMed ID: 9261328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of c-fms and c-kit ligands on the lineage development of the lymphohematopoietic cell line EML C1.
    Tsai S.
    Cancer Chemother Pharmacol; 1996 Aug; 38 Suppl():S58-63. PubMed ID: 8765419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.